Live Breaking News & Updates on இன்றியமையாதது தடுப்பூசி உருட்டல்

Delays Over Pricing Hold Back India s Vital Vaccine Rollout
Delays Over Pricing Hold Back India s Vital Vaccine Rollout
On Sunday, Serum s billionaire Chief Executive Officer Adar Poonawalla said Indian officials have orally agreed to buy 100 million doses at a special price of 200 rupees a shot, below the about $4 to $5 price tag given to the U.K. government.
A health worker opens a deep freezer during a Covid-19 vaccine dry run in Delhi, Jan. 2.
Highlights
Officials have orally agreed to buy 100 million doses at Rs 200: Serum
Over 10 million people have been affected by the virus in India
As major countries like the U.S. and China race to vaccinate their populations with rapidly approved shots, tens of millions of doses prepared for India are sitting in storage despite having been authorized for use. ....

Andhra Pradesh , New Delhi , Abhishek Sharma , Amit Thadani , Narendra Modi , Adar Poonawalla , Malini Aisola , Randeep Guleria , Krishna Ella , Rajesh Bhushan , Ramana Laxminarayan , Serum Institute Of India Ltd , Astrazeneca Plc , Bharat Biotech International Ltd , India Drug Action Network , Pfizer Inc , Indira Ghandi International Airport , Serum Institute , India Institute Of Medical Sciences , Delays Over Pricing Hold Back India , Vital Vaccine Rollout , Chief Executive Officer Adar Poonawalla , Prime Minister Narendra Modi , All India Institute , Medical Sciences , Health Secretary Rajesh Bhushan ,